Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer's disease pathology in mice

All drug trials completed to date have fallen short of meeting the clinical endpoint of significantly slowing cognitive decline in Alzheimer's disease (AD) patients. In this study, we repurposed two FDA-approved drugs, Fasudil and Lonafarnib, targeting synaptic formation (i.e., Wnt signaling) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Christiana Bjorkli (Author), Mary Hemler (Author), Joshua B. Julian (Author), Axel Sandvig (Author), Ioanna Sandvig (Author)
Format: Book
Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available